474 related articles for article (PubMed ID: 30030966)
1. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009650. PubMed ID: 30030966
[TBL] [Abstract][Full Text] [Related]
2. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD009650. PubMed ID: 36511181
[TBL] [Abstract][Full Text] [Related]
3. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Hurley MN; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2013 Feb; (2):CD009650. PubMed ID: 23450608
[TBL] [Abstract][Full Text] [Related]
4. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Hurley MN; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2015 Feb; (2):CD009650. PubMed ID: 25927091
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
8. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
[TBL] [Abstract][Full Text] [Related]
9. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
Ahmed MI; Mukherjee S
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011581. PubMed ID: 30052271
[TBL] [Abstract][Full Text] [Related]
10. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
Ahmed MI; Mukherjee S
Cochrane Database Syst Rev; 2016 Mar; 3():CD011581. PubMed ID: 27003247
[TBL] [Abstract][Full Text] [Related]
11. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.
Loeb MB; Main C; Eady A; Walker-Dilks C
Cochrane Database Syst Rev; 2003; (4):CD003340. PubMed ID: 14583969
[TBL] [Abstract][Full Text] [Related]
13. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
14. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright CE; Smyth AR
Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
[TBL] [Abstract][Full Text] [Related]
15. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
Rosenfeld M; Rayner O; Smyth AR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
[TBL] [Abstract][Full Text] [Related]
17. Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.
Muhlebach MS; Beckett V; Popowitch E; Miller MB; Baines A; Mayer-Hamblett N; Zemanick ET; Hoover WC; VanDalfsen JM; Campbell P; Goss CH;
Thorax; 2017 Apr; 72(4):318-326. PubMed ID: 27852955
[TBL] [Abstract][Full Text] [Related]
18. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
[TBL] [Abstract][Full Text] [Related]
19. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Higgins C; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546
[TBL] [Abstract][Full Text] [Related]
20. Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
Jennings MT; Boyle MP; Weaver D; Callahan KA; Dasenbrook EC
Trials; 2014 Jun; 15():223. PubMed ID: 24925006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]